Obama administration reiterates opposition to device tax repeal; Taking bets on the USSC Myriad Genetics decision;

 @FierceMedDev: Does J&J's latest metal hip lawsuit boost the number to 10,001? Article | Follow @FierceMedDev

 @DamianFierce: Private equity firms are weighing bids for PRA as the CRO mulls an IPO. Story | Follow @DamianFierce

 @MarkHFierce: Here's my first Berlin interview - it's about a nanotech tumor treatment company called MagForce AG. Cool stuff. Editor's corner | Follow @MarkHFierce

 @MichaelGFierce: New research further reveals nano-gold's delivery potential, safety risk. More | Follow @MichaelGFierce

> Health & Human Services Secretary Kathleen Sebelius says the Obama administration will not back any repeal of the 2.3% medical device tax. Story

> Reuse of single-use critical medical devices should not take place until further research can better define risks and benefits of the practice, The Society of Gastroenterology Nurses and Associates has said. Item

> ImmuneTech won FDA clearance for MyAllergyTest, a new at-home allergy diagnostic for 10 common allergens such as grass, cats, dust mites and mold. Story

> A major D.C. patent attorney predicts that the U.S. Supreme Court will rule against Myriad Genetics, determining that human genes aren't patentable. Story

> FDA officials granted 510(k) clearance to Blue Belt Technologies' new knee implant system as a treatment for two kinds of osteoarthritis. Item

> Cancer Research UK and its commercial arm, Cancer Research Technology, will work with biomarker company Abcodia to develop new blood diagnostics that detect a variety of early-stage cancers. Item

> Meridian Bioscience won FDA clearance for a pneumonia-focused molecular diagnostic test. Item

Biotech News

 @FierceBiotech: Shire chief focuses on deal-making, trials with eye to revving up sales. More | Follow @FierceBiotech

 @JohnCFierce: Dynavax tumbles after FDA blocks shortcut on hepatitis B vax salvage operation. Article | Follow @JohnCFierce

 @RyanMFierce: NIH for Health, BGI, Broad Institute, others ally to share Big Data in genomics (special lack of pharma players?) More | Follow @RyanMFierce

 @EmilyMFierce: Scientists discover new antibacterial molecules to fight anthrax, TB. Report | Follow @EmilyMFierce

> Gilead gains FDA's inside track for hep C drug sofosbuvir. Item

> FDA blasts Aveo one last time for 'uninterpretable' cancer study. Report

> AstraZeneca bags another PhIII therapy in $1.15B Pearl buyout. News

Pharma News

 @FiercePharma: Sanofi joins GSK, MedImmune with 4-in-1 flu vaccine. Article | Follow @FiercePharma

 @EricPFierce: French police are investigating death of 92--year-old man who took recalled Teva diuretic that may contain sedative. Story | Follow @EricPFierce

 @CarlyHFierce: Valeant drops bid for Serbian generics maker. More | Follow @CarlyHFierce

> Patheon having 'Banner' year, with boost from Latin America. More

> New deal part of Soriot's revised strategy to energize AstraZeneca. Story

CRO News

> Celerion targets biologics, vaccine studies with Irish expansion. More

> PRA draws private equity interest as IPO pends. News

> Patheon finally turns a profit after $255M Banner deal. Article

> Boehringer eyes Chinese CMO market with biologics plant. Report

Biotech IT News

> AstraZeneca bolsters software systems for virtual R&D of neuroscience drugs. Article

> NIH, BGI, others ally to share Big Data in genomics. Item

> In latest acquisition, IMS Health scoops up Incential Software. Story

> Pharma giant Boehringer Ingelheim backs startup program Rock Health. More

> GenoSpace joins growing alliance for sharing translational research data. Article

Suggested Articles

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.